High-Density Lipoprotein-Targeted Therapies-Not Dead Yet-Reply

Affiliations

¹ South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
² Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

Comment

Stephen J Nicholls et al. JAMA Cardiol. 2018.

. 2018 Dec 1;3(12):1255-1256.

doi: 10.1001/jamacardio.2018.3973.

¹ South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
² Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

No abstract available

Comment on

Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial.
Nicholls SJ, Puri R, Ballantyne CM, Jukema JW, Kastelein JJP, Koenig W, Wright RS, Kallend D, Wijngaard P, Borgman M, Wolski K, Nissen SE. Nicholls SJ, et al. JAMA Cardiol. 2018 Sep 1;3(9):806-814. doi: 10.1001/jamacardio.2018.2112. JAMA Cardiol. 2018. PMID: 30046837 Free PMC article. Clinical Trial.
High-Density Lipoprotein-Targeted Therapies-Not Dead Yet.
Garcia-Ropero A, Santos-Gallego CG, Badimon JJ. Garcia-Ropero A, et al. JAMA Cardiol. 2018 Dec 1;3(12):1254-1255. doi: 10.1001/jamacardio.2018.3962. JAMA Cardiol. 2018. PMID: 30484828 No abstract available.